johnson

Johnson & Johnson Vision Completes Acquisition of Device Manufacturer TearScience

SANTA ANA, Calif.—Johnson Johnson Vision has completed its previously announced acquisition of TearScience Inc., a medical device manufacturer that focuses on evaluating meibomian gland health and treating Meibomian Gland Dysfunction (MGD), the leading cause of dry eye disease. In an announcement earlier this week, JJ Vision said the transaction represents another step in its strategy to become “a broad-based, global leader in eye health and further expands the company’s leading eye health portfolio.” In addition, JJ Vision noted that the acquisition marks its expansion into dry eye medical device technology and provides “a complementary eye health solution to address an…


Johnson & Johnson Vision to Acquire TearScience

SANTA ANA, Calif.—Johnson Johnson Vision (NYSE:JNJ) announced it will acquire TearScience through Abbott Medical Optics, its surgical vision operating company, according to a company press release. Financial terms of the acquisition, which is expected to close by the end of the year, were not disclosed. TearScience has FDA clearance for an office-based approach to imaging Meibomian glands and treating meibomian gland dysfunction, the leading underlying cause of dry eye disease, the release said. “The innovative portfolio from TearScience positively impacts the lives of patients around the world suffering from this chronic condition. These solutions, coupled with our existing contact lens…


Johnson & Johnson Sees Sales Growth Accelerating in Second Half of 2017

NEW BRUNSWICK, N.J.—Johnson Johnson (NYSE: JNJ) reported Tuesday that its sales in the second quarter rose 1.9 percent to $18.8 billion, in part a reflection of sales growth within its medical devices business segment (specifically the cardiovascular business and the Acuvue contact lens product line). Adjusted net earnings totaled $5.0 billion in the quarter, representing an increase of 3.1 percent. Both sales and earnings results are compared to the same period in 2016. Operational sales results increased 2.9 percent, with the negative impact of currency at 1 percent, according to JJ’s announcement. Domestic sales increased 1.6 percent in the quarter….


Johnson & Johnson Vision Champions Eye Health Advocates With New Advocacy Academy

JACKSONVILLE, Fla.—Johnson Johnson Vision Care Inc. announced the launch of Advocacy Academy, an on-demand virtual learning tool designed, the company said, to educate, empower and mobilize a new community of eye health advocates to engage with lawmakers, agencies and patient associations on key issues impacting eye health. Advocacy Academy is the latest addition to the company’s Vision to Action advocacy efforts. The online self-paced modules are designed with generational learning styles in mind and provide guidance to eye health professionals who have an interest in sharing their expertise and insights with lawmakers, agencies and associations to effectively advocate for policies…


Johnson & Johnson Vision Names Jonathan Talamo as Chief Medical Officer

Dr. Jonathan Talamo.​ NEW BRUNSWICK, N.J.—Johnson Johnson Vision Care has named Dr. Jonathan Talamo as its new chief medical officer (CMO) and worldwide vice president of medical affairs and clinical affairs for Johnson Johnson Vision, which comprises both its vision care and surgical businesses. The move is effective “starting in early July,” the company said in its announcement. Dr. Talamo is an internationally known ophthalmologist with more than 25 years of experience. “Dr. Talamo is recognized in the eye health community as a leader who is on the cutting edge of innovation,” Peter Shen, global head of RD for Johnson…